Work

Impact of apheresis-to-infusion interval on outcomes and toxicity of CAR-T therapy in relapsed/refractory DLBCL

Year: 2025
Type: conference-abstract
Source: Blood
Authors: Ajinkya Buradkar, Ahmad Al-Alwan, Francisco Hernandez-Ilizaliturri
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7108469306
Cites:
Cited by:
Related to: